Vitasora Health Limited (ASX:VHL)
Australia · Delayed Price · Currency is AUD 0.0220
-0.0010 (-4.35%)
At close: Jan 22, 2026
Vitasora Health Company Description
Vitasora Health Limited researches, develops, and commercializes medical devices in Australia and the United States.
It is also involved in the production of mobile health applications. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025.
The company is headquartered in Melbourne, Australia.
Vitasora Health Limited
| Country | Australia |
| Founded | 1987 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 30 |
| CEO | Marjan Mikel |
Contact Details
Address: 432 St Kilda Road Melbourne, VIC 3004 Australia | |
| Phone | 61 3 9653 9160 |
| Website | vitasorahealth.com.au |
Stock Details
| Ticker Symbol | VHL |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000392748 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Marjan Mikel B.Sc., M.A.I.C.D. | Chief Executive Officer, MD and Executive Director |
| Nicholas Smedley | Executive Chairman |
| Peter Hildebrandt | Chief Operations Officer |
| Dr. Samaneh Sarraf Shirazi | Chief Research Officer |
| William Sigsbee | Head of US Operations and Chief Commercial Officer for the US market |
| Justin Mouchacca B.Bus (Acc), C.A. | Joint Company Secretary |
| Nova Anne Taylor | Joint Company Secretary |
| Prof. Noam Gavriely D.Sc., M.D. | Medical and Scientific Advisor |
| Simon Godfrey FRCP, FRCPCH, M.D., Ph.D. | Medical and Scientific Advisor |